Theravance Biopharma, Inc. (TBPH)
17.03
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
Theravance Biopharma Price to Book Value : 3.050 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 3.050 |
| October 01, 2026 | 3.050 |
| September 30, 2026 | 3.050 |
| September 29, 2026 | 3.050 |
| September 28, 2026 | 3.050 |
| September 25, 2026 | 3.050 |
| September 24, 2026 | 3.050 |
| September 23, 2026 | 3.050 |
| September 22, 2026 | 3.050 |
| September 21, 2026 | 3.054 |
| September 18, 2026 | 3.049 |
| September 17, 2026 | 3.052 |
| September 16, 2026 | 3.050 |
| September 15, 2026 | 3.052 |
| September 14, 2026 | 3.050 |
| September 11, 2026 | 3.047 |
| September 10, 2026 | 3.049 |
| September 09, 2026 | 3.056 |
| September 08, 2026 | 3.056 |
| September 04, 2026 | 3.059 |
| September 03, 2026 | 3.059 |
| September 02, 2026 | 3.058 |
| September 01, 2026 | 3.050 |
| August 31, 2026 | 3.052 |
| August 28, 2026 | 3.054 |
| Date | Value |
|---|---|
| August 27, 2026 | 3.052 |
| August 26, 2026 | 3.050 |
| August 25, 2026 | 3.050 |
| August 24, 2026 | 3.047 |
| August 21, 2026 | 3.047 |
| August 20, 2026 | 3.036 |
| August 19, 2026 | 3.043 |
| August 18, 2026 | 3.036 |
| August 17, 2026 | 3.031 |
| August 14, 2026 | 3.040 |
| August 13, 2026 | 3.031 |
| August 12, 2026 | 3.031 |
| August 11, 2026 | 3.031 |
| August 10, 2026 | 3.029 |
| August 07, 2026 | 3.032 |
| August 06, 2026 | 3.031 |
| August 05, 2026 | 3.027 |
| August 04, 2026 | 3.024 |
| August 03, 2026 | 3.022 |
| July 31, 2026 | 3.020 |
| July 30, 2026 | 3.018 |
| July 29, 2026 | 3.018 |
| July 28, 2026 | 3.025 |
| July 27, 2026 | 3.020 |
| July 24, 2026 | 3.020 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Viatris, Inc. | 1.426 |
| Ocular Therapeutix, Inc. | 2.939 |
| ANI Pharmaceuticals, Inc. | 2.776 |
| Corcept Therapeutics, Inc. | 17.77 |
| Veru, Inc. | 1.508 |
Price to Book Value Related Metrics
| PE Ratio | 16.87 |
| PS Ratio | 8.486 |
| PEG Ratio | 0.0509 |
| Price to Free Cash Flow | 16.47 |
| Price | 17.03 |
| Earnings Yield | 5.93% |
| Market Cap | 883.70M |
| PEGY Ratio | 0.0509 |
| Operating PE Ratio | 400.71 |
| Normalized PE Ratio | 14.24 |